Skip navigation

Calls to Action

copy number variants

Results can impact the lives of people with autism today

Study finds that comprehensive use of copy number variant genetic testing offers important tool in individualized diagnosis, treatment

April 24, 2014

NEW YORK, N.Y. (April 24, 2014) – A new study from investigators with the Autism Genome Project,  the world’s largest research project on identifying genes associated with risk for autism, has found that the comprehensive use of copy number variant (CNV) genetic testing offers an important tool in individualized diagnosis and treatment of autism.

Discoveries support CNV genetic testing for personalized diagnosis and treatment of autism subtypes and associated medical conditions
April 24, 2014

Researchers with the Autism Genome Project are calling for the broad use of a relatively new type of genetic test – for copy number variants (CNVs) – as the next step in individualized diagnosis and treatment of autism.